🇺🇸 FDA
Company

Contineum

Contineum Therapeutics

CTNM pharma USA

Quick answer

Contineum is a pharma company (CTNM) headquartered in SAN DIEGO, CA, USA with 7 tracked pipeline programs.

Pipeline (7)

project

PIPE-307 Dose A

Relapsing Remitting Multiple Sclerosis

Phase 2 · small_molecule · completed

1 trials project

PIPE-505

Sensorineural Hearing Loss

Phase 2 · small_molecule · completed

1 trials project

PIPE-791 Dose A

Idiopathic Pulmonary Fibrosis

Phase 2 · small_molecule · active

1 trials project

PIPE-307

Multiple Sclerosis

Phase 1 · small_molecule · completed

2 trials project

PIPE-791

Chronic Osteoarthritis Pain

Phase 1 · small_molecule · completed

1 trials project

PIPE-791

Idiopathic Pulmonary Fibrosis (IPF)

Phase 1 · small_molecule · completed

1 trials project

PIPE-791

Multiple Sclerosis

Phase 1 · small_molecule · completed

1 trials

Patents (2)

patent

US 12390462

Muscarinic acetylcholine M1 receptor antagonists

Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12054487

Muscarinic acetylcholine M1 receptor antagonists

Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)